Detalhe da pesquisa
1.
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies.
Pharmacoepidemiol Drug Saf
; 29(12): 1532-1539, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146901